Achilles Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Achilles Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Achilles Therapeutics | 20-F: Registration statement / Annual report / Transition report
Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(1.9%),Invus Public Equities Advisors, LLC(1.9%), etc.
Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(8.1%),Baker Bros. Advisors (GP) LLC(8.1%), etc.
Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Achilles Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Achilles Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Achilles Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Achilles Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Achilles Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Achilles Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Achilles Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Achilles Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Achilles Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Achilles Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Achilles Therapeutics: FY2022 Annual Report
20-F | Achilles Therapeutics plc (0001830749) (Filer)
Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(3.9%),Jeremy C. Green(3.9%)
Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(9.9%),Baker Bros. Advisors (GP) LLC(9.9%), etc.
Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.6%),Point72 Capital Advisors, Inc.(3.6%), etc.
No Data